The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: KRAS vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_004985.5(KRAS):c.519T>C (p.Asp173=)

CA135582

41449 (ClinVar)

Gene: KRAS
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: ecd3287d-e567-4c6a-ad88-0fcb872a517d
Approved on: 2024-12-03
Published on: 2025-03-31

HGVS expressions

NM_004985.5:c.519T>C
NM_004985.5(KRAS):c.519T>C (p.Asp173=)
NC_000012.12:g.25209843A>G
CM000674.2:g.25209843A>G
NC_000012.11:g.25362777A>G
CM000674.1:g.25362777A>G
NC_000012.10:g.25254044A>G
NG_007524.1:g.46078T>C
NG_007524.2:g.46161T>C
ENST00000557334.6:c.180T>C
ENST00000685328.1:c.519T>C
ENST00000686877.1:c.*490T>C
ENST00000687356.1:c.*217T>C
ENST00000688228.1:n.993T>C
ENST00000688940.1:c.519T>C
ENST00000690406.1:c.322T>C
ENST00000690804.1:c.*480T>C
ENST00000692768.1:c.321T>C
ENST00000693229.1:c.444T>C
ENST00000256078.10:c.*73T>C
ENST00000311936.8:c.519T>C
ENST00000256078.8:c.*73T>C
ENST00000311936.7:c.519T>C
ENST00000557334.5:c.180T>C
NM_004985.4:c.519T>C
NM_033360.3:c.*73T>C
NM_001369786.1:c.*73T>C
NM_001369787.1:c.519T>C
NM_033360.4:c.*73T>C
More

Benign

Met criteria codes 3
BP7 BP4 BA1
Not Met criteria codes 3
BS1 PP3 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for KRAS Version 2.3.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.519T>C variant in the KRAS gene is a synonymous (silent) variant (p.Asp173=) at a nucleotide that is not conserved as shown by UCSC browser, and not predicted by SpliceAI to impact splicing (BP4, BP7). The filtering allele frequency in gnomAD v2.1.1 is 0.2201 (28382/128282 alleles with 3073 homozygotes) in the European (non-Finnish) population, which is higher than the ClinGen RASopathy VCEP threshold (>0.0005) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets criteria to be classified as benign for autosomal dominant RASopathies based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy Variant Curation Expert Panel: BA1, BP4, BP7 (Specification Version 2.3, 12/3/2024)
Met criteria codes
BP7
The c.519T>C variant in the KRAS gene is a synonymous (silent) variant (p.Asp173=) at a nucleotide that is not conserved as shown by UCSC browser, and not predicted by SpliceAI to impact splicing
BP4
The c.519T>C variant in the KRAS gene is a synonymous (silent) variant (p.Asp173=) at a nucleotide that is not conserved as shown by UCSC browser, and not predicted by SpliceAI to impact splicing
BA1
The filtering allele frequency in gnomAD v2.1.1 is 0.2201 (28382/128282 alleles with 3073 homozygotes) in the European (non-Finnish) population, which is higher than the ClinGen RASopathy VCEP threshold (>0.0005) for BA1, and therefore meets this criterion (BA1).
Not Met criteria codes
BS1
The filtering allele frequency in gnomAD v2.1.1 is 0.2201 (28382/128282 alleles with 3073 homozygotes) in the European (non-Finnish) population, which meets BA1
PP3
The c.519T>C variant in the KRAS gene is a synonymous (silent) variant (p.Asp173=) at a nucleotide that is not conserved as shown by UCSC browser, and not predicted by SpliceAI to impact splicing
PM2
The filtering allele frequency in gnomAD v2.1.1 is 0.2201 (28382/128282 alleles with 3073 homozygotes) in the European (non-Finnish) population, which meets BA1
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.